ESC Professional Premium Access

Clinical characteristics, patient selection and clinical outcomes of tafamidis treatment in transthyretin amyloidosis cardiomyopathy

Congress Presentation

About the speaker

Doctor Seiji Takashio

Kumamoto University, Kumamoto (Japan)
0 follower

6 more presentations in this session

Diagnostic accuracy of amyloid scintigraphy for the histopathological diagnosis of cardiac transthyretin amyloidosis - a retrospective Austrian multicenter study

Speaker: Doctor N. Verheyen (Graz, AT)


The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis

Speaker: Assistant Professor A. Briasoulis (Iowa City, US)


Hypertension is associated with more advanced heart failure in african americans with suspected cardiac amyloidosis

Speaker: Doctor S. Manjunath (Saint Louis, US)


Atrial fibrillation as a prognostic factor for all-cause mortality in patients with transthyretin amyloid cardiomyopathy

Speaker: Professor R. Witteles (Palo Alto, US)


Histological validation of cardiac 99mTc-DPD uptake in patients with cardiac transthyretin amyloidosis

Speaker: Doctor M. Ungericht (Innsbruck, AT) Associate Professor G. Polzl (Innsbruck, AT)


Access the full session

Chronic heart failure - Amyloidosis

Speakers: Doctor S. Takashio, Doctor N. Verheyen, Assistant Professor A. Briasoulis, Doctor S. Manjunath, Professor R. Witteles...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb